Impact of Antiresorptive Agents on Maxillary Bones: a Narrative Literature Review

Matos, Maria Luiza da Silva; OIiveira, Pedro Henrique Bastos de; Sanches, Ana Carla Barletta; Freire, Tila Fortuna Costa; Dantas, Juliana Borges de Lima; Carrera, Manoela.
J. health sci. (Londrina) ; 23(4): 268-276, 20211206.
Artigo em Inglês | LILACS-Express | ID: biblio-1354020

Documentos relacionados

  1. Review and update on drugs related to the development of osteonecrosis of the jaw.
  2. Dental Implant Placement in Patients With a History of Medications Related to Osteonecrosis of the Jaws: A Systematic Review.
  3. [Medication-related osteonecrosis of the jaws associated with the use of bone-modifying agents].
  4. Adjusted protocol for dental extractions in oncology patients taking anti-resorptive drugs may reduce occurrence of medication-related osteonecrosis of the jaw.
  5. Cilostazol and Tocopherol in the Management of Medication-Related Osteonecrosis of the Jaw: New Insights From a Case Report.
  6. Terapia fotodinâmia como coadjuvante no tratamento da osteonecrose dos maxilares associada ao uso de medicamentos (OMAM)
  7. Medication-Related Osteonecrosis of the Jaw Associated in a Patient Treated With Etanercept.
  8. Medication-Related Osteonecrosis of the Jaws in the Pediatric Population.
  9. Prognosis of medication-related osteonecrosis of the jaws in cancer patients using antiresorptive agent zoledronic acid.
  10. Quality of life in patients affected by medication-related osteonecrosis of the jaws: A systematic review.